These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11118855)

  • 21. From the Centers for Disease Control and Prevention. Performance evaluation programs for determining HIV-1 viral loads, testing for HIV p24 antigen, and identifying Mycobacterium tuberculosis using nucleic acid amplification tests.
    JAMA; 1997 Mar; 277(10):786. PubMed ID: 9052697
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV-1 ICD p24 antigen detection in ugandan infants: use in early diagnosis of infection and as a marker of disease progression.
    Guay LA; Hom DL; Kabengera SR; Piwowar-Manning EM; Kataaha P; Ndugwa C; Marum LH; Kalyesubula I; Jackson JB
    J Med Virol; 2000 Dec; 62(4):426-34. PubMed ID: 11074470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum HIV-1 p24 antibody, HIV-1 RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
    Mofenson LM; Harris DR; Rich K; Meyer WA; Read JS; Moye J; Nugent RP; Korelitz J; Bethel J; Pahwa S
    AIDS; 1999 Jan; 13(1):31-9. PubMed ID: 10207542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin.
    Merigan TC; Hirsch RL; Fisher AC; Meyerson LA; Goldstein G; Winters MA
    AIDS; 1996 Feb; 10(2):159-65. PubMed ID: 8838703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid, Fully Automated Digital Immunoassay for p24 Protein with the Sensitivity of Nucleic Acid Amplification for Detecting Acute HIV Infection.
    Cabrera C; Chang L; Stone M; Busch M; Wilson DH
    Clin Chem; 2015 Nov; 61(11):1372-80. PubMed ID: 26369787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of immunocomplex-dissociated serum HIV-1 p24 antigenemia and plasma HIV-1 viral load: assessment of 3,129 paired assays.
    Manfredi R; Borderi M; Re MC; Furlini G; Monari P; Spinosa Guzmán SM; Tadolini M; Talò S; Donzelli C; Maldini C; Chiodo F
    New Microbiol; 1999 Jul; 22(3):269-75. PubMed ID: 10423746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Survival and disease progression in 251 patients with HIV-1 infection. Study of p24 antigen and viral burden as prognosis makers. Their value at 4 years of follow-up].
    Rubio Caballero M; Rubio Rivas C; Nogués Biau A; Falguera Sacrest M; Manonelles Fernández A
    An Med Interna; 2001 Oct; 18(10):517-20. PubMed ID: 11766280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS.
    Jurriaans S; Weverling GJ; Goudsmit J; Boogaard J; Brok M; Van Strijp D; Lange J; Koot M; Van Gemen B
    AIDS Res Hum Retroviruses; 1995 Apr; 11(4):473-9. PubMed ID: 7632462
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early diagnosis of vertical HIV infection in infants by rapid detection of immune complex-dissociated HIV p24 antigen.
    Panakitsuwan S; Yoshihara N; Hashimoto N; Miyamura K; Chotpitayasunondh T
    AIDS Patient Care STDS; 1997 Dec; 11(6):429-33. PubMed ID: 11361864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia.
    Sabin CA; Lepri AC; Devereux H; Phillips AN; Loveday C; Lee CA
    J Infect Dis; 2001 Aug; 184(4):511-4. PubMed ID: 11471111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance evaluation programs for determining HIV-1 viral loads, testing for HIV p24 antigen, and identifying Mycobacterium tuberculosis using nucleic acid amplification tests.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Feb; 46(7):155-6. PubMed ID: 9072675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of HIV-1 viral load in pregnancy.
    Lillo FB; Bucceri AM; Bettini P; Farma E; Boeri E; Mastrorilli E; Rossi G; Vignali M; Varnier OE
    AIDS; 1997 Sep; 11(11):1397-8. PubMed ID: 9302452
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment-induced decline of human immunodeficiency virus-1 p24 and HIV-1 RNA in lymphoid tissue of patients with early human immunodeficiency virus-1 infection.
    Kuster H; Opravil M; Ott P; Schlaepfer E; Fischer M; Günthard HF; Lüthy R; Weber R; Cone RW
    Am J Pathol; 2000 Jun; 156(6):1973-86. PubMed ID: 10854220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring the response to antiretroviral therapy in HIV-1 group O infected patients using two new RT-PCR assays.
    de Mendoza C; Lu W; Machuca A; Sainz M; Castilla J; Soriano V
    J Med Virol; 2001 Jul; 64(3):217-22. PubMed ID: 11424107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p24 as a predictor of mortality in a cohort of HIV-1-infected adults in rural Africa.
    Erikstrup C; Kallestrup P; Zinyama-Gutsire RB; Gomo E; Lüneborg-Nielsen M; Gerstoft J; Schüpbach J; Ullum H; Katzenstein TL
    J Acquir Immune Defic Syndr; 2008 Jul; 48(3):345-9. PubMed ID: 18545150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasensitive quantitative HIV-1 p24 antigen assay adapted to dried plasma spots to improve treatment monitoring in low-resource settings.
    Knuchel MC; Tomasik Z; Speck RF; Lüthy R; Schüpbach J
    J Clin Virol; 2006 May; 36(1):64-7. PubMed ID: 16431154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The prognostic markers of HIV infection progression. A study of the p24 antigen in a cohort of 251 patients].
    Rubio Caballero M; Nogués Biau A; Falguera Sacrest M; Puig Ganau T
    An Med Interna; 1999 Sep; 16(9):447-50. PubMed ID: 10609356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of laboratory tests and clinical symptoms for identification of primary HIV infection.
    Hecht FM; Busch MP; Rawal B; Webb M; Rosenberg E; Swanson M; Chesney M; Anderson J; Levy J; Kahn JO
    AIDS; 2002 May; 16(8):1119-29. PubMed ID: 12004270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in virologic markers as predictors of CD4 cell decline and progression of disease in human immunodeficiency virus type 1-infected adults treated with nucleosides. AIDS Clinical Trials Group Protocol 175 Team.
    Fiscus SA; Hughes MD; Lathey JL; Pi T; Jackson B; Rasheed S; Elbeik T; Reichman R; Japour A; Byington R; Scott W; Griffith BP; Katzenstein DA; Hammer SM
    J Infect Dis; 1998 Mar; 177(3):625-33. PubMed ID: 9498441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the antiviral capacity of primary natural killer cells by optimized in vitro quantification of HIV-1 replication.
    He X; Simoneau CR; Granoff ME; Lunemann S; Dugast AS; Shao Y; Altfeld M; Körner C
    J Immunol Methods; 2016 Jul; 434():53-60. PubMed ID: 27094484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.